Kezar Life Sciences
85 hedge funds and large institutions have $40.4M invested in Kezar Life Sciences in 2024 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 29 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.52% less ownership
Funds ownership: 6.83% → 6.31% (-0.52%)
14% less capital invested
Capital invested by funds: $47M → $40.4M (-$6.6M)
21% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 29
Holders
85
Holding in Top 10
1
Calls
$2K
Puts
$1K
Top Buyers
1 | +$1.59M | |
2 | +$623K | |
3 | +$481K | |
4 |
TCM
Tang Capital Management
San Diego,
California
|
+$345K |
5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$213K |
Top Sellers
1 | -$2.17M | |
2 | -$1.9M | |
3 | -$1.81M | |
4 |
![]()
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$827K |
5 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$579K |